The Cooper Companies to Present at Upcoming Financial Conferences

PLEASANTON, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced that it will present at two upcoming financial conferences.  Albert G. White III, Executive Vice President, Chief Financial Officer & Chief Strategy Officer, will represent the Company.

• The Baird 2017 Healthcare Conference in New York, NY on September 6, 2017 at 12:15 PM ET.   
• The Wells Fargo Securities 2017 Healthcare Conference in Boston, MA on September 7, 2017 at 8:50 AM ET.

A live audio webcast of each presentation will be available on the Investor Relations section of the Company's website at www.coopercos.com.

About The Cooper CompaniesThe Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.

COO-G

Source: The Cooper Companies, Inc.

CONTACT:

Kim Duncan
Vice President, Investor Relations
The Cooper Companies, Inc.
[email protected]

You May Also Be Interested In

• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
• Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order
• Granite Asia Ranked No. 1 Leading Financial Firm in Singapore for 2026, Metaclade Research Finds